ICU Medical, Inc. (ICUI) key performance indicators and operating metrics (12 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Diluted Earnings Per Share (Adjusted) | 1.97 USD_per_share | FY2026-Q1 |
| Total ICU Adjusted Revenue | 526M | FY2026-Q1 |
| Revenue from Consumables | 278.3M | FY2026-Q1 |
| Revenue from Vital Care | 72.3M | FY2026-Q1 |
| Adjusted Revenue (Consumables) | 278M | FY2026-Q1 |
| Adjusted Revenue (Infusion Systems) | 180M | FY2026-Q1 |
| Adjusted Revenue (Vital Care) | 68M | FY2026-Q1 |
| Consumables Revenue Growth (Reported) | -5.00 percent | FY2026-Q1 |
| Infusion Systems Revenue Growth (Reported) | 8.00 percent | FY2026-Q1 |
| Total ICU Year-Over-Year Growth | -12.00 percent | FY2026-Q1 |
| Vital Care Revenue Growth (Reported) | -59.00 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 105.9M | FY2025-Q3 |
Back to ICUI overview · ICUI earnings · ICUI holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.